KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Goodwill (2016 - 2023)

Historic Goodwill for Inovio Pharmaceuticals (INO) over the last 15 years, with Q2 2023 value amounting to $10.5 million.

  • Inovio Pharmaceuticals' Goodwill changed 0.0% to $10.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $10.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.5 million for FY2022, which is 0.0% changed from last year.
  • Per Inovio Pharmaceuticals' latest filing, its Goodwill stood at $10.5 million for Q2 2023, which was down 0.0% from $10.5 million recorded in Q1 2023.
  • Inovio Pharmaceuticals' Goodwill's 5-year high stood at $10.5 million during Q1 2019, with a 5-year trough of $10.5 million in Q1 2019.
  • Its 5-year average for Goodwill is $10.5 million, with a median of $10.5 million in 2019.
  • Over the last 5 years, Inovio Pharmaceuticals' Goodwill had its largest YoY gain of 0.0% in 2019, and its largest YoY loss of 0.0% in 2019.
  • Over the past 5 years, Inovio Pharmaceuticals' Goodwill (Quarter) stood at $10.5 million in 2019, then changed by 0.0% to $10.5 million in 2020, then changed by 0.0% to $10.5 million in 2021, then changed by 0.0% to $10.5 million in 2022, then changed by 0.0% to $10.5 million in 2023.
  • Its Goodwill was $10.5 million in Q2 2023, compared to $10.5 million in Q1 2023 and $10.5 million in Q4 2022.